Mutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sites

Journal of Medical Genetics

Volumn 33, Issue 10, 1996, Pages 814-819

  Durocher, Francine ^a   Tonin, Patricia ^b   Shattuck Eidens, Donna ^c   Skolnick, Mark ^c   Narod, Steven A ^b,d   Simard, Jacques ^a  

^a LAVAL UNIVERSITY   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

^c Myriad Genetic Laboratories   (United States)

^d WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

BRCA1; Breast cancer; Ovarian cancer

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CHROMOSOME 17Q; CLINICAL ARTICLE; CONTROLLED STUDY; DNA FINGERPRINTING; FAMILY HISTORY; FEMALE; FRAMESHIFT MUTATION; GENE MUTATION; GENE SEQUENCE; GERM LINE; HUMAN; JEW; KIDNEY CANCER; OVARY CANCER; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0029908096     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.33.10.814     Document Type: Article

References (14)

1. Foulkes WD, Narod SA. Hereditary breast and ovarian cancer: epidemiology, genetics, screening and predictive testing. Clin Invest Med 1995;18:473-83.
2. Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 1991;48:232-41.
3. Hoskins KF, Stopfer JE, Calzone KA, et al. Assessment and counseling for women with a family history of breast cancer-a guide for clinicians. JAMA 1995;273:577-85.
4. Peto J, Easton DF, Mattews FE, et al. Cancer mortality in relatives of women with breast cancer: the OPCS study. Int J Cancer 1996;65:215-83.
5. Easton DF, Matthews FE, Ford D, et al. Cancer mortality in relatives of women with ovarian cancer: the OPCS study. Int J Cancer 1996;65:284-94.
6. Narod SA, Madlensky L, Bradley L, et al. Hereditary and familial ovarian cancer in Southern Ontario. Cancer 1994; 74:2341-6.
7. Hall JM, Lee MK, Newman B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990;250:1684-9.
8. Narod S, Feunteun J, Lynch HT, et al. Familial breast-ovarian cancer locus on chromosome 17ql2-q23. Lancet 1991;338:82-3.
9. Easton DF, Bishop DT, Ford D, et al. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 1993;52:678-701.
10. Simard J, Feunteun J, Lenoir G, et al. Genetic mapping of the breast-ovarian cancer syndrome to a small interval on chromosome 17ql2-q21 and exclusion of candidate genes 17β-HSD II and KARA. Hum Mol Genet 1993;2:1193-9.
11. Easton DF, Ford D, Bishop DT, and the Breast Cancer Linkage Consortium. Breast and ovarian-cancer incidence in BRCAl-mutation carriers. Am J Hum Genet 1995; 56:265-71.
12. Ford D, Easton DF, Peto J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 1995;57:1457-62.
13. Narod SA, Ford D, Devilee P, et al. A heterogeneity analysis of 145 breast-ovarian cancer families. Am J Hum Genet 1995;56:254-64.
14. Tonin P, Moslehi R, Green R, et al. Linkage analysis of 26 Canadian breast and breast-ovarian cancer families. Hum Genet 1995;5:535-41.